Literature DB >> 12504737

Optic disk drusen.

Claudia Auw-Haedrich1, Flemming Staubach, Heinrich Witschel.   

Abstract

Optic disk drusen occur in 3.4 to 24 per 1,000 population and are bilateral in approximately 75%. Disturbance in the axonal metabolism in the presence of a small scleral canal--regardless of eyelength--is considered responsible for the development. The drusen increase in size, becoming more visible with age due to continuing calcium apposition, and they are associated with visual field defects in a considerable number of patients. Patients do not usually notice these defects, despite their progressive nature over the years, and this indicates an insidious course. A correct diagnosis of optic disk drusen is mandatory, although effective treatment is not yet available. It is most important to differentiate optic disk drusen from papilledema in order to avoid unnecessary neurological examinations, but also to avoid overlooking genuine neurologic disorders. Because optic disk drusen can cause severe visual field defects, patients require individual consultation regarding work issues and whether or not to drive. Optic disk drusen can be accompanied by vascular complications as well. In some cases these vascular changes--for example, choroidal neovascularization--are treatable. Patients with optic disk drusen should undergo regular visual field, IOP, and nerve fiber layer examinations. In patients with deteriorating visual field and borderline IOP, we recommend antiglaucomatous therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12504737     DOI: 10.1016/s0039-6257(02)00357-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  58 in total

1.  Optic disc abnormalities - diagnosis, evolution and influence on visual acuity.

Authors:  Sonja Cekić; Gordana Stanković-Babić; Zlatica Visnjić; Ivan Jovanović; Dijana Risimić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

2.  Peripapillary vessel density in pediatric cases with buried optic disk drusen.

Authors:  Ibrahim Çağrı Türker; Ceylan Uslu Doğan; Saniye Üke Uzun; Dilek Güven
Journal:  Int Ophthalmol       Date:  2021-01-18       Impact factor: 2.031

3.  Optic nerve head Drusen mimicking papilledema.

Authors:  Joachim M Baehring; John S Biestek
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

4.  Anatomical and functional impairment of the nerve fiber layer in patients with optic nerve head drusen.

Authors:  Pablo Gili; Patricia Flores-Rodríguez; María Dolores Martin-Ríos; Carmen Carrasco Font
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-08-17       Impact factor: 3.117

Review 5.  [Optic disc drusen].

Authors:  M Schargus; E Gramer
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

6.  Optic disc drusen precipitating central retinal vein occlusion in young.

Authors:  Srikanta Kumar Padhy; Umesh Chandra Behera
Journal:  BMJ Case Rep       Date:  2019-07-08

Review 7.  Optic Nerve Head Drusen: An Update.

Authors:  Edward Palmer; Jesse Gale; Jonathan G Crowston; Anthony P Wells
Journal:  Neuroophthalmology       Date:  2018-04-25

8.  Fourier-domain optical coherence tomography and adaptive optics reveal nerve fiber layer loss and photoreceptor changes in a patient with optic nerve drusen.

Authors:  Stacey S Choi; Robert J Zawadzki; Mark A Greiner; John S Werner; John L Keltner
Journal:  J Neuroophthalmol       Date:  2008-06       Impact factor: 3.042

9.  In-vivo high resolution imaging of optic nerve head drusen using spectral-domain Optical Coherence Tomography.

Authors:  Ravi K Murthy; Laura Storm; Sandeep Grover; Vikram S Brar; Kakarla V Chalam
Journal:  BMC Med Imaging       Date:  2010-06-07       Impact factor: 1.930

10.  Central serous papillopathy by optic nerve head drusen.

Authors:  Ana Marina Suelves; Ester Francés-Muñoz; Roberto Gallego-Pinazo; Diamar Pardo-Lopez; Jose Luis Mullor; Jose Fernando Arevalo; Manuel Díaz-Llopis
Journal:  Clin Ophthalmol       Date:  2010-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.